Dr Mark D Erickstad, MD in Longview, TX - Medicare Urology

Dr Mark D Erickstad, MD is a medicare enrolled "Urology" physician in Longview, Texas. He went to University Of Texas Southwestern Medical School At Dallas and graduated in 1986 and has 38 years of diverse experience with area of expertise as Urology. He is a member of the group practice Texas Oncology Pa and his current practice location is 802 Medical Dr, Suite 400, Longview, Texas. You can reach out to his office (for appointments etc.) via phone at (903) 757-7871.

Dr Mark D Erickstad is licensed to practice in Texas (license number H2362) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1972570307.

Contact Information

	Dr Mark D Erickstad, MD
	802 Medical Dr, Suite 400, Longview, TX 75605-5100
	(903) 757-7871
	(903) 753-2479

Physician's Profile

Full Name	Dr Mark D Erickstad
Gender	Male
Speciality	Urology
Experience	38 Years
Location	802 Medical Dr, Longview, Texas
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Mark D Erickstad attended and graduated from University Of Texas Southwestern Medical School At Dallas in 1986

NPI Data:

NPI Number: 1972570307
Provider Enumeration Date: 03/03/2006
Last Update Date: 05/18/2015

Medicare PECOS Information:

PECOS PAC ID: 4284736489
Enrollment ID: I20070219000245

Medical Identifiers

Medical identifiers for Dr Mark D Erickstad such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1972570307	NPI	-	NPPES
127746908	Medicaid	TX
P00417180	Other	TX	RR MEDICARE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	H2362 (Texas)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Longview Regional Medical Center	Longview, TX	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Texas Oncology Pa	5395658934	855

News Archive

Three studies of bioTheranostics molecular breast cancer diagnostics presented at symposium

bioTheranostics, a bioMerieux company that discovers, develops and commercializes new molecular diagnostic tests in oncology, reported today findings from three studies using the company's molecular breast cancer assay to predict risk of disease recurrence in individual patients.

Disability does not necessarily follow disease in living to old age

Researchers from Boston Medical Center's (BMC) New England Centenarian Study report that for a substantial proportion of their centenarian subjects, avoiding age-related diseases (i.e. stroke, cardiovascular disease, diabetes) may not be the key to their longevity; rather, the avoidance of disability may be a key feature in their exceptional survival.

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

Cubist Pharmaceuticals, Inc. today announced the early closing of enrollment in its ecallantide Phase 2 program. Ecallantide, in development as therapy to reduce bleeding in on-pump cardiac surgery, is now known as CB-500,929. After a regularly scheduled review meeting, the Data Safety Monitoring Board (DSMB) contacted the company to recommend a temporary suspension in enrollment in one of the CB-500,929 trials, CONSERV-2.

Daewoong, Medivir sign distribution agreement for Xerclear in China and Hong Kong

Medivir AB, a research-based specialty pharmaceutical company focused on infectious diseases, today announced that it has signed an agreement with Daewoong Pharmaceutical Co. Ltd. to exclusively distribute Medivir's unique cold sore treatment Xerclear in China and Hong Kong.

Exposure to EDCs may reduce vitamin D levels in the bloodstream

Exposure to bisphenol A (BPA) and other endocrine-disrupting chemicals (EDCs) may reduce levels of vitamin D in the bloodstream, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Mark D Erickstad allows following entities to bill medicare on his behalf.

Entity Name	Texas Oncology Pa
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1811944101 PECOS PAC ID: 5395658934 Enrollment ID: O20031124000323

News Archive

Three studies of bioTheranostics molecular breast cancer diagnostics presented at symposium

Disability does not necessarily follow disease in living to old age

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

Daewoong, Medivir sign distribution agreement for Xerclear in China and Hong Kong

Exposure to EDCs may reduce vitamin D levels in the bloodstream

Entity Name	Regional Clinics Of Longview
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1407047863 PECOS PAC ID: 7214016559 Enrollment ID: O20080512000372

Three studies of bioTheranostics molecular breast cancer diagnostics presented at symposium

Disability does not necessarily follow disease in living to old age

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

Daewoong, Medivir sign distribution agreement for Xerclear in China and Hong Kong

Exposure to EDCs may reduce vitamin D levels in the bloodstream

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Mark D Erickstad is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Mark D Erickstad, MD Po Box 847176, Dallas, TX 75284-7176 Ph: (903) 237-1800	Dr Mark D Erickstad, MD 802 Medical Dr, Suite 400, Longview, TX 75605-5100 Ph: (903) 757-7871

News Archive

Three studies of bioTheranostics molecular breast cancer diagnostics presented at symposium

Disability does not necessarily follow disease in living to old age

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

Daewoong, Medivir sign distribution agreement for Xerclear in China and Hong Kong

Exposure to EDCs may reduce vitamin D levels in the bloodstream

Urology Doctors in Longview, TX

Adrienne J K Carmack, MD Urology Medicare: Medicare Enrolled Practice Location: 703 E Marshall Ave, Suite 5007, Longview, TX 75601 Phone: 903-315-4455 Fax: 903-315-2466
Dr. Paul Brian Williams, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 802 Medical Dr, Longview, TX 75605 Phone: 903-757-7871 Fax: 903-753-2479
Landon Taylor Erickstad, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 802 Medical Dr Ste 400, Longview, TX 75605 Phone: 903-757-7871 Fax: 903-753-2479
Dr. John M Ferrell, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 703 E Marshall Ave, Suite 5008, Longview, TX 75601 Phone: 903-757-7871 Fax: 903-753-2479
Gid Roger Johnson, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1608 Sweetbriar St, Longview, TX 75604 Phone: 903-297-6000 Fax: 903-297-6250
Dr. Gregory Ashton Edwards, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 802 Medical Dr, Suite 400, Longview, TX 75605 Phone: 903-757-7871 Fax: 903-753-2479
Dr. Timothy W Howes, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 703 E Marshall Ave, Suite 5008, Longview, TX 75601 Phone: 903-757-7871 Fax: 903-753-2479

Dr Mark D Erickstad, MD - Medicare Urology in Longview, TX

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Three studies of bioTheranostics molecular breast cancer diagnostics presented at symposium

Disability does not necessarily follow disease in living to old age

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

Daewoong, Medivir sign distribution agreement for Xerclear in China and Hong Kong

Exposure to EDCs may reduce vitamin D levels in the bloodstream

Medicare Reassignments

Three studies of bioTheranostics molecular breast cancer diagnostics presented at symposium

Disability does not necessarily follow disease in living to old age

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

Daewoong, Medivir sign distribution agreement for Xerclear in China and Hong Kong

Exposure to EDCs may reduce vitamin D levels in the bloodstream

Three studies of bioTheranostics molecular breast cancer diagnostics presented at symposium

Disability does not necessarily follow disease in living to old age

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

Daewoong, Medivir sign distribution agreement for Xerclear in China and Hong Kong

Exposure to EDCs may reduce vitamin D levels in the bloodstream

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Three studies of bioTheranostics molecular breast cancer diagnostics presented at symposium

Disability does not necessarily follow disease in living to old age

Enrollment closed early in Cubist Pharmaceuticals' ecallantide Phase 2 program

Daewoong, Medivir sign distribution agreement for Xerclear in China and Hong Kong

Exposure to EDCs may reduce vitamin D levels in the bloodstream

Urology Doctors in Longview, TX